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Identiﬁcation of the Gene Encoding the Enzyme Deﬁcient
in Mucopolysaccharidosis IIIC (Sanﬁlippo Disease Type C)
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John W. Callahan, and Don J. Mahuran
Mucopolysaccharidosis IIIC (MPS IIIC), or Sanﬁlippo C, represents the only MPS disorder in which the responsible gene
has not been identiﬁed; however, the gene has been localized to the pericentromeric region of chromosome 8. In an
ongoing proteomics study of mouse lysosomal membrane proteins, we identiﬁed an unknown protein whose human
homolog, TMEM76, was encoded by a gene thatmaps to 8p11.1. A full-lengthmouse expressed sequence tagwas expressed
in human MPS IIIC ﬁbroblasts, and its protein product localized to the lysosome and corrected the enzymatic defect.
The mouse sequence was used to identify the full-length human homolog (HGSNAT), which encodes a protein with no
homology to other proteins of known function but is highly conserved among plants and bacteria. Mutational analyses
of two MPS IIIC cell lines identiﬁed a splice-junction mutation that accounted for three mutant alleles, and a single
base-pair insertion accounted for the fourth.
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Mucopolysaccharidosis IIIC (MPS IIIC [MIM 252930], or
Sanﬁlippo C), ﬁrst described by Kresse et al.,1 is an auto-
somal recessive disorder characterized by the lysosomal
storage of heparin and heparan sulfate. Clinically, MPS
IIIC is similar to the other three forms of MPS III (A, B,
and D). MPS III has a prevalence in Australia of 1 in 66,000
births, with the IIIC form accounting for 1 in 1,407,000
(MPS Australia). Symptoms can vary in severity, in some
cases including severe CNS involvement but only mild
somatic disease.2 Death usually occurs during the late
teens. The defective enzyme in MPS IIIC is heparin acetyl-
CoA:a-glucosaminide N-acetyltransferase, EC 2.3.1.78 (N-
acetyltransferase).3 Identiﬁcation of the gene (HGSNAT)
encoding this enzyme would facilitate mutational analy-
ses, to elucidate the molecular basis of the disease and to
suggest potential clinical approaches for its treatment.
N-acetyltransferase is a lysosomal membrane protein
whose function is to acetylate the nonreducing, terminal
a-glucosamine residue of intralysosomal heparin or he-
paran sulfate, converting it into a substrate for luminal a-
N-acetyl glucosaminidase. Therefore, N-acetyltransferase
catalyzes the only synthetic reaction known to occur in
the lysosome. To do this, the enzyme uses a cytosolic co-
factor, acetyl–coenzyme A (acetyl-CoA).3 Thus, its substrate
and cofactor are separated by the lysosomal membrane.
The mechanism by which it overcomes this spatial prob-
lem is controversial. Onemodel suggests a ping-pongmech-
anism involving an initial acetylation reaction of the en-
zyme in the cytosol, followed by a transfer of the acetyl
group to the intralysosomal heparin-a-glucosamine resi-
due.4,5 An alternative model proposes that the enzyme op-
erates via a random-order ternary-complex mechanism;
that is, there is no acetylated-enzyme intermediate.6 The
enzyme has proven very difﬁcult to purify but is believed
to be a dimer of 120 kDa subunits containing Asn-linked
oligosaccharides; that is, concanavalin A-binding, with a
pI of ∼7.4, based on {14C}acetyl-CoA labeling experiments.4
It is also postulated that the 120-kDa subunit may only
be the catalytic subunit of a protein complex whose other
unidentiﬁed members are also needed for functionality.4
Mouse lysosomal membrane proteomics.—Lysosomes from
mutant (Beige) and normal mice were isolated, and their
membrane proteins were speciﬁcally extracted by meth-
ods similar to those reported for normal rat,7 for a quan-
titative proteomics8 study (authors’ unpublished data). The
cleavable ICAT (cICAT) reagent kit was obtained from Ap-
plied Biosystems. Procedures were performed according to
the Applied Biosystems protocol. The pools of lysosomal
membrane proteins from each group of mice were sepa-
rately labeled, at their Cys residues, with isotopically heavy
(13C) or light (12C) cICAT reagents and were digested by
trypsin. The ICAT-Cys-containing peptides were isolated by
avidin afﬁnity chromatography. After cleavage, fractions
were analyzed by online reverse-phase liquid chromatog-
raphy-electrospray ionization–tandem mass spectrometry
(MS/MS).
Construction of a mammalian expression vector contain-
ing the full-length mouse homolog of human TMEM76
(HGSNAT).—The full-length cDNA for mouse hgsnat was
ampliﬁed by PCR from an IMAGE clone (BC024084), with
use of primers 5′-CACCATGGGCGCGGGCCCGGCG-3′
and 5′-TCCGATTTTCCAAAACAGCTTCTTTTTATAGAGC-
ACG-3′, and was inserted into the mammalian expression
vector pcDNA3.1d TOPO/V5His (Invitrogen) in frame with
the V5-epitope tag. The ﬁdelity of the cloned DNA was
conﬁrmed by sequencing.
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Table 1. Primers Used to Construct a Full-Length Human cDNA Encoding N-Acetyltransferase
Oligonucleotide
Number Nucleotide Sequence Comment
103154 GCAGCGGGCAGGCAAG 16 nt of the sense strand at the 5′ end of exon 1
103379 GTGATAACAGCATTCAGATTTCCAGTAGACGGTC 34 nt of the antisense strand at the 3′ end of exon 2
103667 GACCTGCTACTGGAAATCTGAATGCTGTTATCAC 34 nt of the antisense strand at the 3′ end of exon 2 (complementary to oligonucleotide 103379)
EJ653 CCAGCAGCACATCTCAGTGGGAGCC 25 nt of the 3′ UTR antisense strand, very close to the coding region
103666 GGCCGTCGACGCAGCGGGCAGGCAAG Adds an SalI site to the 5′ end of oligonucleotide 103154
58961 GGGCGGCCGCCACATCTCAGTGGGAGCC Adds an NotI recognition site at the 5′ end of EJ653






5′ Exon 1–5′ IVS1 CTTCTTTCCTGGCCAGCTC GGAGACGCTGCGCTCGTA 390
3′ IVS1–5′ IVS2 GGAAGCAACTGTTCACACGA AGCCCCAAAGCAAACAGAAC 249
3′ IVS2–5′ IVS4 GTCCTCCAGCAATCAACAG TGCAAATGTGAAAATCAGCAG 573
3′ IVS3–5′ IVS4a GGTTGGAATACAGATTTGGAGA TGGTGCTCATCAATGACCTAA 260
3′ IVS4–5′ IVS5 CTTCCCCTCACTGGTTTTCA GGTGACAGCTGCCCCTTC 249
3′ IVS5–5′ IVS6 GGAAACTATGCTGTCAGAGTTGA CAACCTGGCCTTCCTCAATA 393
3′ IVS6–5′ IVS7 GGGCCACAGAGCGAGACT TGGAGAGGCTGCAGAGTTTA 400
3′ IVS7–5′ IVS8 GCATGATTGCACCTTGTGAG GTGATTCTCCTGCCCTGAAG 250
3′ IVS8–5′ IVS9 CCTCCCCTGGGTTTACTTTC TGGGTCAAGTATGAGAACTATCCA 297
3′ IVS9–5′ IVS10 CCCATGGGGCTATATTCTGA AATGCTCACAGTTAGACAACCA 490
3′ IVS10–5′ IVS11 TGTCTTCCCCTTTAGGAAACAA TTAAGCCTGGGATGTTGAGG 489
3′ IVS11–5′ IVS13 CCAAAAAGGCCAAGAAATGA GGCATGGTTTAACGTTTGCT 1,155
3′ IVS12–5′ IVS13a AGCGATTCTCCTGCATTAGC GGCATGGTTTAACGTTTGCT 492
3′ IVS13–5′ IVS14 GGAGTGTATTCAGGTTTGTATTTGG GGCCCATAGCACAAGAGAGA 296
3′ IVS14–5′ IVS17 CCCTGTAATCCCAGCACCTA CTAGGGCAGTGGCTCAAGAC 1,242
3′ IVS17–5′ end of the 3’ UTR (exon 18) CTGGTTTCAAGAATTAAATAGATGG CAGTGTCTTCCCCCAGAGTC 397
a Additional PCRs were done to verify the mutations.
Transfection of HeLa cells and immunoﬂuorescence staining
and microscopy.—HeLa cells were plated onto glass cover-
slips and were transiently transfected using Lipofectamine
2000, according to themanufacturer’s directions. The cells
were ﬁxed with 4% paraformaldehyde 24 h after trans-
fection and were immunostained as described elsewhere.9
LAMP1 (H4A3) antibody was from the Developmental
Studies Hybridoma Bank at the University of Iowa. Anti-
V5 rabbit-polyclonal antibody was from Sigma-Aldrich.
Chicken anti-mouse Alexaﬂuor 594 and chicken anti-rab-
bit Alexaﬂuor 488 antibodies (Molecular Probes)were used
as secondary antibodies for immunoﬂuorescence. Confo-
cal images were from an LSM 510 META laser scanning
confocal microscope (Zeiss) equippedwith a Plan-Apochro-
mat 63# (NA 1.4) oil DIC objective. Contrast and bright-
ness of images were adjusted using Adobe Photoshop. The
N-acetyltransferase activity was also determined for pools
of HeLa cells transfected with the V5-His6–tagged and un-
tagged mouse IMAGE clone and our full-length human
HGSNAT cDNA (see below). These activities were com-
pared with the endogenous levels of untransfected HeLa
cells (see below).
Generation of a full-length human HGSNAT cDNA.—The
cDNA of the human HGSNAT gene (which, when defec-
tive, causes MPS IIIC) was constructed through RT-PCR.
Dimethyl sulfoxide (10%) was kept in both the RT and
PCR, because of high GC-rich content at the 5′ region of
the cDNA.
The total RNA was extracted from HeLa cells using
RNeasy Mini Kit (Qiagen) according to themanufacturer’s
instructions. The ﬁrst-strand cDNA was synthesized using
Thermoscript (Invitrogen) as the reverse transcriptase. The
RNA, primer EJ653 (table 1), and deoxyribonucleotide tri-
phosphates were mixed and heated at 95C for 5 min.
After cooling to 60C, the prewarmed mixture of enzyme
and dithiothreitol was added, and the reaction was pro-
cessed at 60C for 50 min. The reaction was stopped by
heating at 85C for 5 min, and the RNA was digested by
RNase H at 37C for 1 h. The synthesized ﬁrst-strand cDNA
was used as template in the PCR or was kept at 20C for
further use.
The double-stranded fragment containing the last 34
nt of exons 2–18 was ampliﬁed by PCR. In this reaction,
ProofStart (Qiagen) was used as the polymerase, the above
ﬁrst-strand cDNA as template, and oligonucleotides
103667 and EJ653 as primers (table 1). In the cycling pro-
gram, the conditions used were 94C for 30 s for dena-
turing, 60C for 30 s for annealing, and 72C for 1 min
40 s for extension. After 35 cycles, the ﬁnal 72C extension
step was performed over a 10-min period. The double-
stranded fragment containing exons 1–2 was ampliﬁed by
the same technique, except that oligonucleotides 103154
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Figure 1. Identiﬁcation of D8Ertd354e by MS/MS. The lysosomal
membrane proteins from mutant (Beige) and normal mice were
labeled with either isotopically heavy (13C) or light (12C) cICAT
reagent, were digested with trypsin, and were afﬁnity puriﬁed. The
upper right inset is the MS pattern of a pair of these labeled
peptides. The main spectrogram shows the MS/MS fragmentation
pattern for the Cys-ICAT light–labeled peptide. The obtained pep-
tide sequence is shown at the upper left. *C indicates the labeled
Cys residue.
Figure 2. The epitopically expressed mouse D8Ertd354e (N-acetyltransferase) localizes to lysosomes in HeLa cells. C-terminal V5-
epitope–tagged mouse N-acetyltransferase cDNA was transiently expressed in HeLa cells. The ﬁxed cells were processed for indirect
immunoﬂuorescence confocal microscopy. N-acetyltransferase was detected with V5-antibody (green), whereas lysosomes were detected
with LAMP-1 (H4A3) antibody (red). The merged images show substantial overlap between the signals (yellow), which indicates colo-
calization. mm.Barp 10
and 103379 (table 1) were used as primers and 72C for
30 s was used for extension.
The full-length double-stranded cDNA of the HGSNAT
gene was ampliﬁed by the same technique, except that
the 72C extension step was for 2 min. In this PCR, the
above two overlapping PCR fragments—instead of the
ﬁrst-strand cDNA—were used as the template, and oligo-
nucleotides 103666 and 58961 were used as primers (ta-
ble 1). Finally, the ampliﬁed full-length cDNA was sub-
cloned into the expression plasmid pCMVsport6 (Invitro-
gen) through its SalI and NotI sites. The sequences of the
two fragments and the ﬁnal full-length cDNA were con-
ﬁrmed by automatic sequencing.
Transfections and expression of N-acetyltransferase in pa-
tient ﬁbroblasts.—Fibroblasts from patients with MPS IIIC
were transfected by electroporation (Human Dermal Fibro-
blast Nucleofector Kit [Amaxa]), according to the manu-
facturer’s instructions. In brief, ∼106 cells were suspended
in 100 ml of nucleofector solution and 2 mg of plasmid
DNA containing our V5-His6–tagged or untagged mouse
homolog (positive control), or a candidate full-length hu-
man cDNA-encoding N-acetyltransferase was added, and
electroporation was done using program U-23. Electro-
porated cells were then replated and harvested 20 h after
transfection. Levels of N-acetyltransferase and b-hexosa-
minidase (Hex) were then determined fromwhole-cell ho-
mogenates. Hex activities were used to normalize the ac-
tivities obtained from the N-acetyltransferase, HGSNAT.
Assay for N-acetyltransferase activity.—The method we
used to assay N-acetyltransferase activity was based on the
original work of Voznyi et al.10 This is a coupled assay with
use of the substrate 4-methylumbelliferyl-b-D-glucosamin-
ide (MU-bGlcNH2). Although heparan sulfate contains only
a-glucosamine residues, Voznyi et al.10 found that N-ace-
tyltransferase is active toward either the a- or b-anomer.
In the presence of acetyl-CoA, N-acetyltransferase con-
verts MU-bGlcNH2 to MU-bGlcNAc, which is a substrate
for Hex, which results in the production of free ﬂuorescent
MU. If whole-cell homogenates are being assayed, their
endogenous Hex is sufﬁcient for the assay. In brief, cells
were washed (in 2# PBS), were resuspended in 0.2Mphos-
phate/0.1 M citrate buffer (pH 5.5) containing 0.2% heat-
inactivated BSA, and were freeze-thawed six times. Then,
10 ml of the homogenate was mixed with 10 ml of 12 mM
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Figure 3. Chromosomal localization and structure of the human HGSNAT gene and the predicted topology of the enzyme it encodes,
N-acetyltransferase, with its 11 TMDs (A–K) after the cleavage of the signal peptide. The exons and their encoded protein domain,
shown in red, are unique to higher metazoans. Red circles on the protein diagram represent the positions of putative Asn-linked
oligosaccharide sites, and the green triangles delineate the sections of the protein encoded by each of the 18 exons in HGSNAT.
acetyl-CoA and 10 ml of 3 mM MU-bGlcNH2 in 0.2 M
phosphate/0.1 M citrate buffer (pH 5.5) containing 0.25%
Triton X-100. The reaction mixture was incubated at 37C
for 17 h. Reaction was terminated by adding 200 ml MAP
(pH 110), and the ﬂuorescence of the reaction-product,
MU, was read. The endogenous Hex activity was deter-
mined separately, as described elsewhere,11 to normalize
the N-acetyltransferase activity
Mutational analyses.—Fibroblasts established from two
unrelated patients (4172 and 8861)—who are from the
same rural area in eastern Canada and who received bio-
chemical and clinical diagnoses of MPS IIIC—were ana-
lyzed for mutations in their HGSNAT genomic DNA and
cDNA. The genomic structure of the HGSNAT gene was
established by the sequence of our cDNA clone, combined
with mouse full-length cDNA and the UCSC Genome Bio-
informatics databases. The genomic DNA from the pa-
tients’ ﬁbroblasts and one control cell line were isolated
using DNeasy Tissue Kit (Qiagen). We ampliﬁed all exons
and intron-exon boundaries inHGSNAT. PCRprimerswere
designed using the Primer3 program (table 2). PCR prod-
ucts were puriﬁed, either by QiaQuick columns or from
an excised gel band, with use of the QIAquick Gel Ex-
traction Kit (Qiagen) and were bidirectionally sequenced
with BigDye Terminator V3.1 cycle sequencing kit and
3100Genetic Analyzer (AppliedBiosystems)byACGTCorp.
We ampliﬁed the cDNA from the two patients and a con-
trol individual, using oligonucleotides 5′-ATGGATCAGG-
CTTTGCTACTCATTC-3′ and 5′-CTCCTCCATAATTGACA-
AAGACC-3′ as primers. The product, which spanned exons
2–8, was puriﬁed and sequenced. We also conﬁrmed the
presence of the splice-site mutation (see below) by restric-
tion digestion of a 574-bp genomic PCR fragment, gen-
erated using oligonucleotides 5′-TGGTGCTCATCAATG-
ACCTAA-3′ and 5′-GAGTCCAAAAGCAGGGAAGC-3′ as
primers, with BsiWI (data not shown), performed accord-
ing to the manufacturer’s instructions (New England
Biolabs).
Northern-blot analysis.—Northern blotting was done on
a Human Multiple Tissue Northern Blot (Clontech). The
cDNA probe for human HGSNAT was PCR ampliﬁed from
the cDNAwith oligonucleotides 103667 and EJ653 as prim-
ers (see above). The probe for human actin was supplied
by the manufacturer. The Multiple Tissue Northern Blot
was probed with 32P-cytidine–labeled cDNA, according to
the manufacturer’s directions.
Identiﬁcation of the mouse homolog of human N-acetyl-
transferase.—As part of an unrelated proteomics study com-
paring mutant (Beige) and normal mouse lysosomal mem-
brane proteins, one pair of ICAT-labeled–Cys-containing
tryptic peptides, detected by MS (ﬁg. 1 [inset]), was identi-
ﬁed by MS/MS as D8Ertd354e (ﬁg. 1), the mouse homolog
of human TMEM76. Since this protein had no known
function or identiﬁable functional domain, originated from
lysosomal membranes, and its human homolog mapped
to 8p11.1, we considered TMEM76 a strong candidate for
the elusive MPS IIIC enzyme. Several apparently full-length
mouse ESTs (mRNAs) were found in the Human Genome
Browser Gateway database (position: human chromosome
8 43114000–43178000). One, BC024084 (GeneID 52120),
was available as an IMAGE clone (5101064).
The IMAGE clone encoding mouse D8Ertd354e was
transiently transfected into human MPS IIIC ﬁbroblasts.
The N-acetyltransferase activity in pools of transfected
MPS IIIC cells was ∼200-fold higher than in untransfected
cells. A V5-His6 epitope tag was placed at the C-terminus
of the IMAGE clone and was similarly expressed in HeLa
and humanMPS IIIC ﬁbroblasts. Immunoﬂuorescencemi-
croscopy of transfected HeLa cells demonstrated that the
protein product colocalized with LAMP-1 (ﬁg. 2), and N-
acetyltransferase assays of bothMPS IIIC ﬁbroblasts (∼100-
fold increase) and HeLa cells (∼2-fold increase) demon-
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Figure 4. Aligned primary sequences of N-acetyltransferase from higher metazoans. The predicted human 30-residue, cleavable signal
peptide is shown in a cyan-ﬁlled rectangle. Red circles and green triangles represent putative Asn-linked oligosaccharide sites and
delineate the portions of the protein encoded by each of the 18 exons of the gene, respectively. Black bars indicate the 11 predicted
TMDs (A–K), and the yellow underlined sequence in the mouse is the tryptic peptide we initially identiﬁed by MS/MS (ﬁg. 1).
strated that the tag did not substantially interfere with
function. These data also suggest that (a) the protein may
not be a subunit in a multimeric enzyme complex, since
many such multimers cannot form if one of their subunits
is supplied through the transfection of cells with a cDNA
derived from another species—for example, human Hex
A (a-b heterodimer)12—and (b) the C-terminus of the pro-
tein likely faces the cytosol, since epitope tags usually do
not survive inside lysosomes.13
Identifying the full-length human cDNA homolog of mouse
D8Ertd354e (N-acetyltransferase) and deducing the human
gene structure.—Comparison of the functional mouse se-
quence with existing human sequences identiﬁed it as XP_
372038, ﬁrst seen at the National Center for Biotechnol-
ogy Information (NCBI) database on January 22, 2004.
However, this sequence and two other revisions lacked the
correct full-length N-terminus, as deﬁned by the mouse
sequence. On March 1, 2006, the fourth revision, XP_
372038.4 (Gi:89028035), was added to the database. That
version contained an N-terminus convincingly similar to
the mouse to be considered full length. Using these data
and comparing themwith genomic sequences fromcontig
NC_000008.9, we deduced that the TMEM76 gene, re-
named “HGSNAT” (Gene ID 138050), is 62.4 kb in length
and contains 18 exons (ﬁg. 3). In the course of mutational
analyses (see below), we conﬁrmed the exon- and intron-
exon–junction sequences in the database by PCR (table
2).
Just as full-length human ESTs were apparently difﬁcult
to obtain, we were unsuccessful in generating a full-length
cDNA by a single RT-PCR (see above). The 5′ section of
the human transcript is very GC rich, ∼80%, which may
explain these difﬁculties. We transiently expressed our
full-length human construct in MPS IIIC ﬁbroblasts and
HeLa cells and observed ∼100- and ∼2-fold increases, re-
spectively, in N-acetyltransferase activity, as compared
with untransfected cells of the same type.
Characterization of the human N-acetyltransferase pro-
tein.—The deduced C-terminal half of HGSNAT (exons 7–
18) is highly conserved across species, including plants
and bacteria. However, the N-terminus, extending to trans-
membrane domain (TMD) B, is found only in metazoans
(ﬁgs. 3 and 4). Neither of these regions has homologywith
other functional domains identiﬁed elsewhere, including
those from proteins known to bind CoA or acetyl-CoA.
Thus, theHGSNAT-encodedN-acetyltransferase represents
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Figure 5. Northern-blot analysis of the HGSNAT transcripts in
various human tissues. PBL p peripheral-blood leukocytes.
the human member of a new family of enzymes. The de-
duced primary sequence of human N-acetyltransferase pre-
dicts a 635-aa protein containing a 30-aa, cleavable, N-
terminal signal peptide and 11 TMDs (ﬁg. 3), as predicted
by TMHMMServer v.2.0. This suggests an orientationwith
the 135-aa N-terminal domain inside the endoplasmic re-
ticulum (ER) and, ultimately, the lysosome and the short
8-aa C-terminal domain facing the cytosol (consistent with
the survival of the C-terminal V5-His6 epitope tag; see
above). After signal-peptide cleavage, the predictedMr and
pI are ∼68,000 and 8.4, respectively. There are also ﬁve
consensus sites for Asn-linked glycosylation. On the basis
of our topology predictions, all of these sites would be
synthesized inside the lumen of the ER and thus would
be available for glycosylation (ﬁg. 3). If N-linked oligo-
saccharides were present at all ﬁve sites, they could add
another ∼10 kDa to the protein’s apparent molecular
mass. The pI of the protein could also be lowered and the
apparent Mr further raised if any of these oligosaccharides
were to have a high sialic acid content—for example, the
polylactosaminoglycans found on LAMP-1 and LAMP-2.14
Characterization of mutant HGSNAT alleles in two MPS
IIIC–affected patient cell lines.—Mutational analyses were
initially performed by RT-PCR, oligonucleotide 103379,
and oligonucleotide EJ653 (table 1) (nucleotides189–1946).
As compared with normal samples, samples from patient
1 contained only a lower-weight cDNA band, and the
cDNA from patient 2 separated into two main bands. One
corresponded to the lower weight band seen in patient 1,
and the other was of apparent normal length. Further
PCRs indicated that the size difference occurred between
nucleotides 189 (exon 2) and 822 (exon 8). The cDNA
bands detected in both patients’ samples were of dimin-
ished intensity (data not shown). Results of sequencing
of the cDNA from patient 1 indicated that it lacked exon
4, which resulted in the generation of a premature stop
codon shortly downstream of the new exon 3/exon 5
splice site (data not shown). Premature stop codons are
often associated with unstable mRNA.15 Sequencing of
each exon and exon-intron junction was undertaken to
conﬁrm the sequence present in the NCBI database and
to identify the mutations in the two patients’ cells. Au-
tomated sequencing of exon 4 and the beginning of intron
4 detected a GrA substitution in the ﬁrst nucleotide of
intron 4 of the HGSNAT gene from patient 1 (data not
shown). Since a GT sequence at the beginning of each
intron is required for splicing,16 this substitution explains
the missing exon 4 sequence in the patient’s cDNA (data
not shown). This substitution also interrupts a BsiWI re-
striction site (CGTACG), which allows us to conﬁrm the
sequence change by amplifying and digesting a 574-bp
PCR fragment spanning the mutation. These data conﬁrm
that patient 1 is homozygous for the splice-junction mu-
tation and demonstrate that patient 2 is heterozygous for
the same mutation (data not shown). Further sequencing
of the genomic DNA from patient 2 revealed the expected
IVS-41GrA substitution and the emergence of two over-
lapping sequences in exon 13 (data not shown). The latter
observation is explained by the insertion of a single G
after nucleotide A1344, resulting in a frameshift after
Gly448 and the generation of a premature stop codon 21
codons downstream.
The determination of the size and tissue distribution of
HGSNAT transcripts.—Transcripts of HGSNAT were ana-
lyzed by northern blotting. These data revealed a major
mRNA species of ∼2.1 kb that is present in all tissues ex-
amined (ﬁg. 5) but is highest in heart, skeletal muscle,
liver, and kidney. The database predicts a transcript size
of 5.1 kb that includes a large 3′ UTR of ∼3 kb, encoded
by exon 18. Such a large exon is rare, and our northern
blot suggests that it may be present only as a minor spe-
cies—for example, in heart and skeletal muscle (ﬁg. 5).
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